Services
ION CHANNEL SCREENING SERVICES
Ion channel screening
High-throughput screening
CARDIAC SAFETY SCREENING SERVICES
Cardiac Safety Screening
GLP hERG Testing
Non-GLP hERG Screening
A clinically translatable hiPSC cardiomyocyte assay for early cardiac derisking
hiPSC-derived Cardiomyocyte Screening
Chronic Cardiotoxicity Assay: hiPSC-derived Cardiomyocytes
CiPA Screening
NEUROSCIENCE SERVICES
Neuroscience
CNS drug discovery: Brain slice tissue
Native Neuronal Ion Channels
Central Neuronal Firing
Peripheral Neuronal Firing
Neuroscience translational assays
INTEGRATED SERVICES
Integrated Drug Discovery
Who we are
Why Metrion?
Why Choose Metrion As Your CRO?
Who we work with
Leadership
Metrion Board
Metrion Leadership Team
About Metrion
Metrion Company History
Mission, Vision, Values
Metrion Annual Reports
Join Metrion
Careers
Knowledge Library
KNOWLEDGE LIBRARY
Resources
News & Events
News
News and Press Releases
Events
Upcoming Events
Contact
CONTACT
Contact
EN/日本語
English
日本語
Services
ION CHANNEL SCREENING SERVICES
Ion channel screening
High-throughput screening
CARDIAC SAFETY SCREENING SERVICES
Cardiac Safety Screening
GLP hERG Testing
Non-GLP hERG Screening
A clinically translatable hiPSC cardiomyocyte assay for early cardiac derisking
hiPSC-derived Cardiomyocyte Screening
Chronic Cardiotoxicity Assay: hiPSC-derived Cardiomyocytes
CiPA Screening
NEUROSCIENCE SERVICES
Neuroscience
CNS drug discovery: Brain slice tissue
Native Neuronal Ion Channels
Central Neuronal Firing
Peripheral Neuronal Firing
Neuroscience translational assays
INTEGRATED SERVICES
Integrated Drug Discovery
Who we are
Why Metrion?
Why Choose Metrion As Your CRO?
Who we work with
Leadership
Metrion Board
Metrion Leadership Team
About Metrion
Metrion Company History
Mission, Vision, Values
Metrion Annual Reports
Join Metrion
Careers
Knowledge Library
KNOWLEDGE LIBRARY
Resources
News & Events
News
News and Press Releases
Events
Upcoming Events
Contact
CONTACT
Contact
EN/日本語
English
日本語
Home
>
News and Press Releases
>
Blog
>
Page 5
Filters
Filters
Resource Type
- Select Resource Type -
Blog
Topic
- Select Topic -
Cardiac Safety Screening
Corporate
Ion Channel Screening
Neuroscience
Show
(
60
)
Cancel
An Interview with Damian Bell
July 10, 2020
Read More
Metrion welcomes new sales and marketing intern, Anna
July 7, 2020
Read More
Improving Cardiac Safety Testing Protocols
July 5, 2020
Read More
Metrion is open for business
March 31, 2020
Read More
Metrion’s CEO reflects on participation in Goldman Sachs’ 10,000 Small Businesses UK
March 3, 2020
Read More
Why Metrion’s CSO spent 35 years unlocking the potential of ion channels for drug discovery
November 6, 2019
Read More
Nav1.5(Late) Cardiac Safety Assay on QPatch
August 31, 2019
Read More
Opportunities for Ion Channel Targeting Antibodies: Current Landscape and Pipeline
July 31, 2019
Read More
An Interview with Professor Nikita Gamper
July 2, 2019
Read More
ELRIG: Advances in Cell Based Screening – Gothenburg, Sweden
July 2, 2019
Read More
« Previous
1
…
3
4
5
6
Next »
DisPATCHes newsletter
Subscribe to DisPATCHes newsletter
Let’s work together
Contact us for a quote or discussion
Search metrionbiosciences.com
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
About Metrion
Metrion Biosciences is a contract research organisation (CRO) specialising in high-quality preclinical drug discovery services.
Visit our LinkedIn
Visit our Twitter
Links
Ion Channel Screening
Cardiac Safety Screening
Neuroscience
Integrated Drug Discovery
Our Approach
Knowledge Library
News & Events
Contact
SUBSCRIBE TO NEWSLETTER
Copyright © 2024 Metrion. All rights reserved |
Privacy notice
| Registered as a company in England and Wales: 09669815 | VAT: GB 219828479
magnifier
linkedin
facebook
pinterest
youtube
rss
twitter
instagram
facebook-blank
rss-blank
linkedin-blank
pinterest
youtube
twitter
instagram
